Literature DB >> 17513715

Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease.

Sylvia Frisancho-Kiss1, Sarah E Davis, Jennifer F Nyland, J Augusto Frisancho, Daniela Cihakova, Masheka A Barrett, Noel R Rose, Delisa Fairweather.   

Abstract

Recent clinical studies have reinforced the importance of sex-related differences in the pathogenesis of cardiovascular diseases, with an increased incidence and mortality in men. Similar to humans, male BALB/c mice infected with coxsackievirus B3 (CVB3) develop more severe inflammation in the heart even though viral replication is no greater than in females. We show that TLR4 and IFN-gamma levels are significantly elevated and regulatory T cell (Treg) populations significantly reduced in the heart of males following CVB3 infection, whereas females have significantly increased T cell Ig mucin (Tim)-3, IL-4 and Treg. Blocking Tim-3 in males significantly increases inflammation and TLR4 expression while reducing Treg. In contrast, defective TLR4 signaling significantly reduces inflammation while increasing Tim-3 expression. Cross-regulation of TLR4 and Tim-3 occurs during the innate and adaptive immune response. This novel mechanism may help explain why inflammatory heart disease is more severe in males.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513715     DOI: 10.4049/jimmunol.178.11.6710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  89 in total

Review 1.  Gender differences in autoimmunity associated with exposure to environmental factors.

Authors:  K Michael Pollard
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

Review 2.  Immune cells have sex and so should journal articles.

Authors:  Sabra L Klein
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

3.  Regulation of dendritic cell differentiation and function by estrogen receptor ligands.

Authors:  Susan Kovats; Esther Carreras
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

Review 4.  TIM-1 and TIM-3 proteins in immune regulation.

Authors:  Ee Wern Su; Jean Y Lin; Lawrence P Kane
Journal:  Cytokine       Date:  2008-08-15       Impact factor: 3.861

Review 5.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

Review 6.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

7.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

Review 8.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 9.  Heart failure in cancer: role of checkpoint inhibitors.

Authors:  Murilo Delgobo; Stefan Frantz
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

10.  Republished: pathogenesis and diagnosis of myocarditis.

Authors:  Chantal Elamm; Delisa Fairweather; Leslie T Cooper
Journal:  Postgrad Med J       Date:  2012-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.